(Image: Getty/Oatawa)

Almac expands neo-antigen peptide manufacturing

By Maggie Lynch

Almac announced it has increased its supply of neo-antigen peptides for individualized cancer treatments with the addition of another stream of GMP manufacturing.

(Image: iStock/kasto80)

ATCC adds novel in vitro model to expanding portfolio

By Melissa Fassbender

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.

Animal models allow researchers to recapitulate what occurs in a human being with cancer. (Image: iStock/anyaivanova)

Charles River mulls moonshots and mouse models

By Melissa Fassbender

Charles River Laboratories is conducting new studies using animal models to give insight into therapeutic strategies where pharma companies expect to see the most success.


Follow us


View more


Featured Suppliers